297 related articles for article (PubMed ID: 10347121)
1. Characterization of a reproducible rat model of hepatic veno-occlusive disease.
DeLeve LD; McCuskey RS; Wang X; Hu L; McCuskey MK; Epstein RB; Kanel GC
Hepatology; 1999 Jun; 29(6):1779-91. PubMed ID: 10347121
[TBL] [Abstract][Full Text] [Related]
2. Reliable experimental model of hepatic veno-occlusive disease caused by monocrotaline.
Chen MY; Cai JT; Du Q; Wang LJ; Chen JM; Shao LM
Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):395-400. PubMed ID: 18693175
[TBL] [Abstract][Full Text] [Related]
3. Support of sinusoidal endothelial cell glutathione prevents hepatic veno-occlusive disease in the rat.
Wang X; Kanel GC; DeLeve LD
Hepatology; 2000 Feb; 31(2):428-34. PubMed ID: 10655267
[TBL] [Abstract][Full Text] [Related]
4. A murine model of hepatic veno-occlusive disease induced by allogeneic hematopoietic stem cell transplantation.
Zeng L; An L; Fang T; Pan B; Sun H; Chen C; Cao J; Li Z; Xu K
Cell Biochem Biophys; 2013; 67(3):939-48. PubMed ID: 23579582
[TBL] [Abstract][Full Text] [Related]
5. Hepatic regeneration is decreased in a rat model of sinusoidal obstruction syndrome.
Schiffer E; Frossard JL; Rubbia-Brandt L; Mentha G; Pastor CM
J Surg Oncol; 2009 Jun; 99(7):439-46. PubMed ID: 19353590
[TBL] [Abstract][Full Text] [Related]
6. Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: the role of glutathione and relevance to hepatic venoocclusive disease.
DeLeve LD; Wang X; Kuhlenkamp JF; Kaplowitz N
Hepatology; 1996 Mar; 23(3):589-99. PubMed ID: 8617441
[TBL] [Abstract][Full Text] [Related]
7. Hepatic microvasculature in liver injury.
DeLeve LD
Semin Liver Dis; 2007 Nov; 27(4):390-400. PubMed ID: 17979075
[TBL] [Abstract][Full Text] [Related]
8. [Effects of liver sinusoid endothelial cell injury in mouse hepatic veno-occlusive disease].
Fang T; An LC; Liu MM; Hua J; Xu KL; Zeng LY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1457-62. PubMed ID: 23257453
[TBL] [Abstract][Full Text] [Related]
9. Sorafenib attenuates monocrotaline-induced sinusoidal obstruction syndrome in rats through suppression of JNK and MMP-9.
Nakamura K; Hatano E; Narita M; Miyagawa-Hayashino A; Koyama Y; Nagata H; Iwaisako K; Taura K; Uemoto S
J Hepatol; 2012 Nov; 57(5):1037-43. PubMed ID: 22796153
[TBL] [Abstract][Full Text] [Related]
10. Embolization by sinusoidal lining cells obstructs the microcirculation in rat sinusoidal obstruction syndrome.
DeLeve LD; Ito Y; Bethea NW; McCuskey MK; Wang X; McCuskey RS
Am J Physiol Gastrointest Liver Physiol; 2003 Jun; 284(6):G1045-52. PubMed ID: 12584111
[TBL] [Abstract][Full Text] [Related]
11. Decreased hepatic nitric oxide production contributes to the development of rat sinusoidal obstruction syndrome.
DeLeve LD; Wang X; Kanel GC; Ito Y; Bethea NW; McCuskey MK; Tokes ZA; Tsai J; McCuskey RS
Hepatology; 2003 Oct; 38(4):900-8. PubMed ID: 14512877
[TBL] [Abstract][Full Text] [Related]
12. Basement membrane and matrix metalloproteinases in monocrotaline-induced liver injury.
Hanumegowda UM; Copple BL; Shibuya M; Malle E; Ganey PE; Roth RA
Toxicol Sci; 2003 Nov; 76(1):237-46. PubMed ID: 12970574
[TBL] [Abstract][Full Text] [Related]
13. Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease).
DeLeve LD; Shulman HM; McDonald GB
Semin Liver Dis; 2002 Feb; 22(1):27-42. PubMed ID: 11928077
[TBL] [Abstract][Full Text] [Related]
14. The mouse model of hepatic veno-occlusive disease.
An L; L X; Chu X; Liu X; Zhang Y; Wang Y; Wang Y; Liu Y
Pak J Pharm Sci; 2021 Nov; 34(6(Special)):2391-2400. PubMed ID: 35039250
[TBL] [Abstract][Full Text] [Related]
15. Tissue remodeling following submassive hemorrhagic necrosis in rat livers induced by an intraperitoneal injection of dimethylnitrosamine.
Jin YL; Enzan H; Kuroda N; Hayashi Y; Nakayama H; Zhang YH; Toi M; Miyazaki E; Hiroi M; Guo LM; Saibara T
Virchows Arch; 2003 Jan; 442(1):39-47. PubMed ID: 12536313
[TBL] [Abstract][Full Text] [Related]
16. The flavonoid monoHER prevents monocrotaline-induced hepatic sinusoidal injury in rats.
Ezzat T; van den Broek MA; Davies N; Dejong CH; Bast A; Malagó M; Dhar DK; Olde Damink SW
J Surg Oncol; 2012 Jul; 106(1):72-8. PubMed ID: 22287334
[TBL] [Abstract][Full Text] [Related]
17. Diannexin, a novel annexin V homodimer, provides prolonged protection against hepatic ischemia-reperfusion injury in mice.
Teoh NC; Ito Y; Field J; Bethea NW; Amr D; McCuskey MK; McCuskey RS; Farrell GC; Allison AC
Gastroenterology; 2007 Aug; 133(2):632-46. PubMed ID: 17681182
[TBL] [Abstract][Full Text] [Related]
18. Early stellate cell activation and veno-occlusive-disease (VOD)-like hepatotoxicity in dogs treated with AR-H047108, an imidazopyridine proton pump inhibitor.
Berg AL; Böttcher G; Andersson K; Carlsson E; Lindström AK; Huby R; Håkansson H; Skånberg-Wilhelmsson I; Hellmold H
Toxicol Pathol; 2008 Jul; 36(5):727-37. PubMed ID: 18648100
[TBL] [Abstract][Full Text] [Related]
19. Experimental acute hepatic vein occlusion: histological observations in the rat.
Manenti A; Martinelli AM; Botticelli L; Botticelli AR
Pathologica; 1995 Oct; 87(5):522-4. PubMed ID: 8868179
[TBL] [Abstract][Full Text] [Related]
20. The septic abscess wall: a cytokine-generating organ associated with portal venous cytokinemia, hepatic outflow fibrosis, sinusoidal congestion, inflammatory cell sequestration, hepatocellular lipid deposition, and focal cell death.
Ceydeli A; Condon MR; Siegel JH
Shock; 2003 Jul; 20(1):74-84. PubMed ID: 12813373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
